1α,25‑Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow‑derived macrophages

Qu X, Zhai Z, Liu X, et al: Dioscin inhibits osteoclast differentiation and bone resorption through down-regulating the Akt signaling cascades. Biochem Biophys Res Commun. 443:658–665. 2014. View Article : Google Scholar : PubMed/NCBI

Lieben L, Carmeliet G and Masuyama R: Calcemic actions of vitamin D: Effects on the intestine, kidney and bone. Best Pract Res Clin Endocrinol Metab. 25:561–572. 2011. View Article : Google Scholar : PubMed/NCBI

Lieben L and Carmeliet G: Vitamin D signaling in osteocytes: Effects on bone and mineral homeostasis. Bone. 54:237–243. 2013. View Article : Google Scholar : PubMed/NCBI

Kogawa M, Anderson PH, Findlay DM, et al: The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol. 121:277–280. 2010. View Article : Google Scholar : PubMed/NCBI

Uchiyama Y, Higuchi Y, Takeda S, et al: ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone. 30:582–588. 2002. View Article : Google Scholar : PubMed/NCBI

Song R, Gu J, Liu X, Zhu J, Wang Q, Gao Q, Zhang J, Cheng L, Tong X, Qi X, et al: Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone. Int J Mol Med. 34:856–862. 2014.PubMed/NCBI

Gu JH, Tong XS, Chen GH, et al: Regulation of matrix metalloproteinase-9 protein expression by 1α,25-(OH)₂D₃ during osteoclast differentiation. J Vet Sci. 15:133–140. 2014. View Article : Google Scholar : PubMed/NCBI

Teitelbaum SL: Osteoclasts: What do they do and how do they do it? Am J Pathol. 170:427–435. 2007. View Article : Google Scholar : PubMed/NCBI

Brinkmann J, Hefti T, Schlottig F, et al: Response of osteoclasts to titanium surfaces with increasing surface roughness: An in vitro study. Biointerphases. 7:342012. View Article : Google Scholar : PubMed/NCBI

Suda T, Takahashi F and Takahashi N: Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies. Arch Biochem Biophys. 523:22–29. 2012. View Article : Google Scholar : PubMed/NCBI

Takasu H, Sugita A, Uchiyama Y, et al: c-Fos protein as a target of anti-osteoclastogenic action of vitamin D and synthesis of new analogs. J Clin Invest. 116:528–535. 2006. View Article : Google Scholar : PubMed/NCBI

Zhu K, Gläser R and Mrowietz U: Vitamin D(3) and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells. Biochem Biophys Res Commun. 297:1211–1217. 2002. View Article : Google Scholar : PubMed/NCBI

Medhora MM, Teitelbaum S, Chappel J, et al: 1 alpha, 25-dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin alpha v beta 3. J Biol Chem. 268:1456–1461. 1993.PubMed/NCBI

Takahashi N, Yamana H, Yoshiki S, et al: Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1373–1382. 1988. View Article : Google Scholar : PubMed/NCBI

DeLuca HF: History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 3:4792014. View Article : Google Scholar : PubMed/NCBI

Arai F, Miyamoto T, Ohneda O, et al: Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med. 190:1741–1754. 1999. View Article : Google Scholar : PubMed/NCBI

Price CP, Kirwan A and Vader C: Tartrate-resistant acid phosphatase as a marker of bone resorption. Clin Chem. 41:641–643. 1995.PubMed/NCBI

Kim TH, Lee B, Kwon E, et al: 1,25-Dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression. Joint Bone Spine. 80:307–314. 2013. View Article : Google Scholar : PubMed/NCBI

Väänänen HK, Liu YK, Lehenkari P and Uemara T: How do osteoclasts resorb bone? Mater Sci Eng C. 6:205–209. 1998. View Article : Google Scholar

Grüneberg S, Stubbs MT and Klebe G: Successful virtual screening for novel inhibitors of human carbonic anhydrase: Strategy and experimental confirmation. J Med Chem. 45:3588–3602. 2002. View Article : Google Scholar : PubMed/NCBI

Väänänen K: Mechanism of osteoclast mediated bone resorption - rationale for the design of new therapeutics. Adv Drug Deliv Rev. 57:959–971. 2005. View Article : Google Scholar : PubMed/NCBI

Xie L, Moroi Y, Hayashida S, et al: Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1α. J Dermatol Sci. 61:45–50. 2011. View Article : Google Scholar : PubMed/NCBI

Ishibashi O, Niwa S, Kadoyama K and Inui T: MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci. 79:1657–1660. 2006. View Article : Google Scholar : PubMed/NCBI